标题
Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
作者
关键词
-
出版物
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 306, Issue 7, Pages H1025-H1031
出版商
American Physiological Society
发表日期
2014-02-15
DOI
10.1152/ajpheart.00795.2013
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Targeting Interleukin-1 in Heart Disease
- (2013) Benjamin W. Van Tassell et al. CIRCULATION
- Blocking Interleukin-1 as a Novel Therapeutic Strategy for Secondary Prevention of Cardiovascular Events
- (2012) Antonio Abbate et al. BIODRUGS
- Inflammatory Cytokines in Heart Failure: Mediators and Markers
- (2012) Lars Gullestad et al. CARDIOLOGY
- Recombinant Human Interleukin-1 Receptor Antagonist Provides Cardioprotection During Myocardial Ischemia Reperfusion in the Mouse
- (2012) Stefano Toldo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Heart Disease and Stroke Statistics—2013 Update
- (2012) Alan S. Go et al. CIRCULATION
- Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse
- (2012) Stefano Toldo et al. EXPERIMENTAL PHYSIOLOGY
- The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β
- (2012) Nathan A. Bracey et al. EXPERIMENTAL PHYSIOLOGY
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
- (2012) Benjamin W. Van Tassell et al. PLoS One
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Right Ventricular Dysfunction following Acute Myocardial Infarction in the Absence of Pulmonary Hypertension in the Mouse
- (2011) Stefano Toldo et al. PLoS One
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
- (2010) Antonio Abbate et al. EUROPEAN JOURNAL OF HEART FAILURE
- Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity
- (2010) Jinzhou Zhu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Increased Cytokine Production in Interleukin-18 Receptor α-deficient Cells Is Associated with Dysregulation of Suppressors of Cytokine Signaling
- (2009) Claudia A. Nold-Petry et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury
- (2009) Kaliyamurthi Venkatachalam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The effect of daily administration of IL-18 on cardiac structure and function
- (2009) A Platis et al. PERFUSION-UK
- Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling
- (2008) Marcin Bujak et al. AMERICAN JOURNAL OF PATHOLOGY
- Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
- (2008) Antonio Abbate et al. CIRCULATION
- Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic Review
- (2008) José Paulo Araújo et al. JOURNAL OF CARDIAC FAILURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More